Walleye Capital LLC Cytokinetics Inc Put Options Transaction History

Walleye Capital LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$47.86 - $75.05 $1.06 Million - $1.67 Million	-22,200 Reduced 90.24%	2,400 $130,000
Q1 2024 May 15, 2024	BUY	$63.75 - $108.06 $401,625 - $680,778	6,300 Added 34.43%	24,600 $1.72 Million
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $249,984 - $776,457	9,300 Added 103.33%	18,300 $1.53 Million
Q3 2023 Nov 14, 2023	SELL	$29.46 - $36.61 $745,338 - $926,233	-25,300 Reduced 73.76%	9,000 $265,000
Q2 2023 Aug 14, 2023	BUY	$32.62 - $40.75 $1.12 Million - $1.4 Million	34,300 New	34,300 $1.12 Million
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $135,926 - $194,218	3,800 Added 422.22%	4,700 $215,000
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $34,686 - $49,068	900 New	900 $44,000
Q2 2020 Aug 14, 2020	SELL	$11.15 - $24.64 $11,150 - $24,640	-1,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$8.75 - $16.3 $8,750 - $16,300	1,000 New	1,000 $12,000

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.9B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.